Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 266
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT02516774 | A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers | ||
NCT04965766 | Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer | ||
NCT03981666 | Video-Based Cognitive Behavioral Therapy for Insomnia in Adults Cancer Patients and Survivors | ||
NCT00920920 | An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer | ||
NCT02215720 | Temsirolimus and Cetuximab in Patients With Advanced or Metastatic Solid Tumors | ||
NCT03982173 | Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors | ||
NCT06479057 | PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy | ||
NCT02831530 | Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients | ||
NCT00181025 | Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle | ||
NCT03285230 | The French E3N Prospective Cohort Study | ||
NCT01226394 | Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients | ||
NCT00180791 | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood | ||
NCT02230176 | Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II | ||
NCT00180882 | LMBA02 Protocol for Patients With a Burkitt Lymphoma | ||
NCT01786031 | Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program | ||
NCT03613194 | Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer | ||
NCT02672527 | Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma | ||
NCT02994576 | Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer | ||
NCT02494973 | Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases | ||
NCT03612791 | Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab | ||
NCT02613962 | Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling | ||
NCT02094391 | Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma | ||
NCT02115165 | A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors | ||
NCT02619565 | Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes | ||
NCT00918320 | Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours | ||
NCT06332274 | tislelizUMaB in canceR Patients With molEcuLar residuaL Disease | ||
NCT00418327 | Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma | ||
NCT04276376 | Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors | ||
NCT00147160 | Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents | ||
NCT01801176 | Peripheral Primitive Fibromatosis | ||
NCT06712472 | Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for P53abn Endometrial Cancer | ||
NCT01864772 | Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC | ||
NCT06364631 | CARE1 Pragmatic Clinical Trial | ||
NCT03519048 | Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma | ||
NCT00126230 | Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer | ||
NCT00180830 | Glivec Phase II Pediatric Study | ||
NCT02856425 | Trial Of Pembrolizumab And Nintedanib | ||
NCT01887522 | Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults | ||
NCT01289522 | Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | ||
NCT04932525 | Gustave Roussy Cancer Profiling | ||
NCT02018874 | A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine | ||
NCT02902874 | Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK + | ||
NCT02260739 | Sequential Analysis in Patients With an Hemopathy | ||
NCT01884922 | Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults | ||
NCT02517125 | Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors | ||
NCT01167530 | Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer | ||
NCT02666625 | Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank | ||
NCT02994225 | Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity | ||
NCT04940325 | Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer | ||
NCT05476939 | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 |